Tirzepatide, with its dual GLP-1/GIP action, may offer additional advantages, particularly in weight loss, fat metabolism, and insulin sensitivity
Small trials suggest potential to reduce cancer-treatment toxicities, but it has not been shown to treat cancer
Recently, Cheng et al
After your initial visit, your follow-up appointments are efficient, supportive, and focused on your progress
Intuitively, small increases in ROS would be expected to activate the PI3-K/Akt pathway preferentially, while further increases would be expected to trigger p38MAPK-dependent apoptosis
These changes likely contribute to easier sleep initiation, deeper delta-dominant sleep, and adaptogenic/stress-protective effects without strong sedation